# PRODUCTION_READINESS_STATUS

## Current overall score
- Overall readiness: **8.0 / 10**
- Date: 2026-05-04
- Interpretation: materially hardened through Prompt 12, but still short of production-final truth.

## Phase summary (single-source truth)
- Phase 0 baseline/readiness: **complete**
- Phase 1 security lockdown: **partial/strong**
- Phase 2 CI/unsafe merge blocking: **partial/strong**
- Phase 3 store isolation/RBAC: **partial**
- Phase 4 idempotency/reservation: **partial**
- Phase 5 stock truth: **partial/strong**
- Phase 6 commercial-flow integration tests: **partial**
- Phase 7 regulated release/H1/vault: **partial/strong**
- Phase 8 payment/refund truth: **partial**
- Phase 9 invoice/GST/statutory billing: **partial**
- Phase 10 accounting/supplier/Tally: **partial**
- Phase 11 product master/migration: **partial**
- Phase 12 barcode production UX: **next**
- Phase 13 placeholder/provider matrix: **pending**
- Phase 14 deployment/monitoring/backup: **pending**
- Phase 15 performance/HTTP hardening: **pending**
- Phase 16 UX/admin polish: **pending**
- Phase 17 training/SOP/smoke checklist: **pending**
- Phase 18 investor/dev audit pack/final audit: **pending**

## Remaining blockers
- duplicate/stale PR cleanup execution on GitHub remote
- barcode production UX / scanner-label workflow
- provider contract matrix
- deployment/observability/backup/restore
- performance/load/HTTP hardening
- deeper DB-backed integration tests
- full route wiring for product master/import
- payment webhook raw-body verified route
- full refund/settlement reconciliation
- full invoice PDF/persistence parity
- full accounting route wiring
- customer/admin UX polish
- training/SOP mode
- final investor/dev audit pack

## Production doctrine (retained)
- No fake-complete modules.
- No unscoped access.
- No unaudited critical mutation.
- No regulated medicine release without compliance truth.
- No stock mutation outside invariant truth.
- No payment/refund without ledger truth.

## Next prompt
`feat/barcode-production-ux`
